Sphera-Funds-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
114
Total Value
419305182
Accession Number
0001496201-25-000007
Form Type
13F-HR
Manager Name
Sphera-Funds-Management
Data Enrichment
92% identified
105 identified9 unidentified

Holdings

114 positions
Manager:
Search and click to pin securities to the top
Page 5 of 6
Oric Pharmaceuticals, Inc.
Shares:234.8K
Value:$1.3M
CEVA INC
Shares:48.9K
Value:$1.3M
BRISTOL MYERS SQUIBB CO
Shares:20.0K
Value:$1.2M
Ventyx Biosciences, Inc.
Shares:1.0M
Value:$1.2M
Nano Dimension Ltd.
Shares:717.5K
Value:$1.1M
Inozyme Pharma, Inc.
Shares:1.2M
Value:$1.1M
Outlook Therapeutics, Inc.
Shares:857.1K
Value:$1.0M
Astria Therapeutics, Inc.
Shares:189.8K
Value:$1.0M
16385C104
Shares:900.4K
Value:$981.5K
Perspective Therapeutics, Inc.
Shares:460.2K
Value:$980.3K
Marvell Technology, Inc.
Shares:15.1K
Value:$927.9K
ARVINAS, INC.
Shares:125.0K
Value:$877.5K
Xenon Pharmaceuticals Inc.
Shares:26.1K
Value:$875.6K
Perion Network Ltd.
Shares:102.6K
Value:$835.3K
Regulus Therapeutics Inc.
Shares:452.8K
Value:$792.5K
Larimar Therapeutics, Inc.
Shares:366.3K
Value:$787.6K
Corvus Pharmaceuticals, Inc.
Shares:205.9K
Value:$654.6K
Werewolf Therapeutics, Inc.
Shares:626.8K
Value:$609.4K
Vir Biotechnology, Inc.
Shares:90.9K
Value:$588.7K
Aprea Therapeutics, Inc.
Shares:270.0K
Value:$550.8K